0001179110-16-033386.txt : 20161222 0001179110-16-033386.hdr.sgml : 20161222 20161222170602 ACCESSION NUMBER: 0001179110-16-033386 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161220 FILED AS OF DATE: 20161222 DATE AS OF CHANGE: 20161222 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMAG PHARMACEUTICALS INC. CENTRAL INDEX KEY: 0000792977 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042742593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 6174983300 MAIL ADDRESS: STREET 1: 1100 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED MAGNETICS INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KELLEY BRIAN P CENTRAL INDEX KEY: 0001269385 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10865 FILM NUMBER: 162067278 4 1 edgar.xml FORM 4 - X0306 4 2016-12-20 0 0000792977 AMAG PHARMACEUTICALS INC. AMAG 0001269385 KELLEY BRIAN P C/O AMAG PHARMACEUTICALS, INC. 1100 WINTER STREET WALTHAM MA 02451 1 0 0 0 Common Stock 2016-12-20 4 A 0 1026 A 1026 D Stock Option (Right to Buy) 35.50 2016-12-20 4 A 0 6000 A 2026-12-20 Common Stock 6000 6000 D Stock Option (Right to Buy) 35.50 2016-12-20 4 A 0 2739 A 2026-12-20 Common Stock 2739 2739 D Each restricted stock unit represents a contingent right to receive one share of Common Stock of AMAG Pharmaceuticals, Inc. (the "Issuer"). These shares of Common Stock are issuable pursuant to a grant of restricted stock units pursuant to the Issuer's Third Amended & Restated 2007 Equity Incentive Plan, as amended (the "Plan") that will vest in five equal monthly installments commencing on January 1, 2017; however, delivery of the shares is deferred until the earlier of (a) one year from the date of grant and (b) the date of the director's separation from service to the Issuer. Not applicable. Grant of stock option pursuant to the Plan. This option will vest and become exercisable in twenty-four equal monthly installments over two years from the date of grant. Grant of stock option pursuant to the Plan. This option will vest and become exercisable in five equal monthly installments commencing January 1, 2017. Nancy R. Smith, attorney-in-fact 2016-12-22